CM
ABBV icon

CastleKnight Management’s AbbVie ABBV Stock Holding History

CastleKnight Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,400
Closed -$389K – 249
2022
Q1 		$389K Hold
2,400
– – 0.06% 197
2021
Q4 		$325K Buy
+2,400
New +$284K 0.07% 145

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CastleKnight Management's ABBV Position: Q2 2022 in Review

CastleKnight Management sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 2,400 shares — an estimated $389K sold.

CastleKnight Management first reported a position in ABBV in Q4 2021 and held it in 2 quarters. The position peaked at $389K in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • CastleKnight Management reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • CastleKnight Management sold 2,400 AbbVie shares in Q2 2022, an estimated $389K.
  • CastleKnight Management first reported a position in AbbVie in Q4 2021 and held it in 2 quarters.
  • CastleKnight Management's AbbVie position peaked at $389K in Q1 2022.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on CastleKnight Management's 13F filing for Q2 2022, filed 15 Aug 2022.